Albemarle Corporation – Consensus Indicates Potential 8.8% Upside
Albemarle Corporation found using ticker (ALB) have now 20 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 440 and 145 with a mean TP of 288.95. With the stocks previous close at 265.7 this would imply there is a potential upside of 8.8%. The 50 day moving average now sits at 226.2 and the 200 day moving average is 227.13. The market capitalisation for the company is $32,980m. Company Website: https:||www.albemarle.com [stock_market_widget type="chart" template="basic" color="green" assets="ALB" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,866m based on the market concensus. Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.
Albemarle Corporation – Consensus Indicates Potential 8.8% Upside
Albemarle Corporation found using ticker (ALB) have now 20 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 440 and 145 with a mean TP of 288.95. With the stocks previous close at 265.7 this would imply there is a potential upside of 8.8%. The 50 day moving average now sits at 226.2 and the 200 day moving average is 227.13. The market capitalisation for the company is $32,980m. Company Website: https:||www.albemarle.com [stock_market_widget type="chart" template="basic" color="green" assets="ALB" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,866m based on the market concensus. Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.